European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
European Business
No Result
View All Result
Home < INDUSTRIES Health

European Wellness Collaborates With Heidelberg University Germany To Conduct Efficacy Studies Of Peptides And Cell Therapy

by Marie Weil
November 3, 2021
A A
Share on LinkedinShare on Twitter

FRANKFURT, Germany, October 25, 2021 – European Wellness Academy (EWA), the educational arm of European Wellness Biomedical Group (EWG), has signed an agreement to carry out joint scientific research on the efficacy of peptides and cell therapy, exosomes and in vivo cell reprogramming for rejuvenation in premature murine aging models in vitro and in vivo.

EWA was earlier represented by its Group Chairman, Prof. Dr. Mike Chan, while Heidelberg University was represented by its Commercial Managing Director, Katrin Erk and its Head of Institute of Anatomy and Cell Biology III, Prof. Dr. Thomas Skutella.

The therapeutics used for the studies are precursor (progenitor) stem cells (PSC), precursor cells (Frozen Organo Crygenics (FOC)), Mito Organelle (MO), Nano Organo Peptides (NOP) and exosomes.

The in vitro experiment of the study concentrates on the effects of the products on the aging of somatic cells in vitro as senescent cells are known to contribute to disease onset and progression through the complex cell and non-cell-autonomous mechanisms. The investigated exosomes include neuronal stem cells (NSCs), mesenchymal stem cells (MSCs), cardiomyocytes, kidney progenitors and hepatocytes.

The subsequent in vivo experiment targets to demonstrate both safety and efficacy of the therapeutics where proof of effectivity are recorded on life span, histopathological and molecular criteria of neurodegeneration including Alzheimer/dementia, and system degeneration disorders including skin, cardio, lung, kidney, liver, stomach/intestine/gut, muscular dystrophy, immune system and eye.

Other criteria included are cartilage/joint/bone regeneration including knees/joints/hips, cervical, thoracic, lumbar, pelvic and musculoskeletal disorder. Endocrine disorders like endocrinal dysfunction due to over and underproduction of hormones and other activity pattern under the sleep wake cycle.

The ongoing specially designed studies was coordinated and designed by Prof. Dr. Thomas Skutella of Heidelberg University, a world-renowned research university and one of Germany’s Top 3, Prof. Dr. Mike Chan and scientists of EWG.

Tags: < Partnership

Related Industries

Health

Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio

January 25, 2023
Health


Philips and Masimo expand partnership to improve telehealth for patients and clinicians around the world

January 19, 2023
Health

Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies

January 10, 2023
Health

AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline

January 10, 2023
Health

Boehringer Ingelheim announces appointments to Board of Managing Directors

December 21, 2022
Health

Sanofi and Innate Pharma expand collaboration for natural killer cell therapeutics in oncology

December 20, 2022

AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline

January 10, 2023

...

L’Oréal unveils two new CES 2023 innovation award-winning beauty technologies

January 5, 2023

...

GlobalLogic to Open New Digital Engineering Centers in Spain

January 17, 2023

...

A. P. Moller – Maersk completes acquisition of project logistics specialist Martin Bencher Group

January 3, 2023

...

DHL Supply Chain opens its largest fully-automated robotic fulfillment center in Germany for Peek & Cloppenburg* Düsseldorf

January 19, 2023

...

Das neue ZF-Vorstandsteam (von links nach rechts): Michael Frick, Dr. Martin Fischer, Vorstandsvorsitzender Dr. Holger Klein, Dr. Peter Laier, Sabine Jaskula und Stephan von Schuckmann.
//
ZF’s newly formed Board of Management team (from left to right): Michael Frick, Dr. Martin Fischer, CEO Dr. Holger Klein, Dr. Peter Laier, Sabine Jaskula and Stephan von Schuckmann.

ZF Kicks Off 2023 With New Executive Management Team

January 13, 2023

...

Stellantis to Build Electric Aircraft with Archer and Provide Strategic Funding for Growth

January 5, 2023

...

Airbus to provide Poland with a very high resolution optical satellite system

January 5, 2023

...

IHG Hotels & Resorts opens global headquarters in Windsor

January 12, 2023

...

A.P. Moller – Maersk and DP World enter a long-term partnership to decarbonise logistics and improve customer services

January 14, 2023

...

Asia Pacific Business Asia Pacific Business Asia Pacific Business

EUROPEAN BUSINESS is a premier source of corporate news, business information and insights across broad spectrum of industries in Europe and worldwide.  We are one of the members of the Business World Network.

RESOURCES

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor # european-biz.com

PARTNERSHIP:     partnership # european-biz.com

HUMAN RESOURCE:     hr # european-biz.com

* (replace # with @)

  • Official Site

Copyright © EUROPEAN-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © EUROPEAN-BIZ.COM All rights reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist